Matches in Nanopublications for { ?s ?p "[IL-15 and IL-2 increase Cetuximab-mediated cellular cytotoxicity against triple negative breast cancer cell lines expressing EGFR.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- assertion description "[IL-15 and IL-2 increase Cetuximab-mediated cellular cytotoxicity against triple negative breast cancer cell lines expressing EGFR.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP493317.RAQAObPP5uQl7VZ-VZ0rysMlQTe1xW9iQ0Mdgk5DIXLZY130_assertion description "[IL-15 and IL-2 increase Cetuximab-mediated cellular cytotoxicity against triple negative breast cancer cell lines expressing EGFR.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP493317.RAQAObPP5uQl7VZ-VZ0rysMlQTe1xW9iQ0Mdgk5DIXLZY130_provenance.
- assertion description "[IL-15 and IL-2 increase Cetuximab-mediated cellular cytotoxicity against triple negative breast cancer cell lines expressing EGFR.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[IL-15 and IL-2 increase Cetuximab-mediated cellular cytotoxicity against triple negative breast cancer cell lines expressing EGFR.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP871328.RAWloNby8n2rKdgUgNwM3SqNlgG06wqL_FoLV7x56WxwE130_assertion description "[IL-15 and IL-2 increase Cetuximab-mediated cellular cytotoxicity against triple negative breast cancer cell lines expressing EGFR.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP871328.RAWloNby8n2rKdgUgNwM3SqNlgG06wqL_FoLV7x56WxwE130_provenance.
- NP871330.RAXPV31mMPr4-_l0-hUuHGemNyJJFkCs78o75tcf_pA2k130_assertion description "[IL-15 and IL-2 increase Cetuximab-mediated cellular cytotoxicity against triple negative breast cancer cell lines expressing EGFR.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP871330.RAXPV31mMPr4-_l0-hUuHGemNyJJFkCs78o75tcf_pA2k130_provenance.
- NP871329.RAlrcbp9ds4Ad1UGTzL8Ta4uvWOidNjFg11hO5TGi7zGo130_assertion description "[IL-15 and IL-2 increase Cetuximab-mediated cellular cytotoxicity against triple negative breast cancer cell lines expressing EGFR.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP871329.RAlrcbp9ds4Ad1UGTzL8Ta4uvWOidNjFg11hO5TGi7zGo130_provenance.
- NP507217.RA2Nv_v5ENnqqJYKCiwav2tXnGQPRQLOf0G3GCVlv6luA130_assertion description "[IL-15 and IL-2 increase Cetuximab-mediated cellular cytotoxicity against triple negative breast cancer cell lines expressing EGFR.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP507217.RA2Nv_v5ENnqqJYKCiwav2tXnGQPRQLOf0G3GCVlv6luA130_provenance.